Bill Amendment: IL HB2259 | 2019-2020 | 101st General Assembly
NOTE: For additional amemendments please see the Bill Drafting List
Bill Title: DHFS-MCO PREFERRED DRUG LISTS
Status: 2019-07-12 - Public Act . . . . . . . . . 101-0062 [HB2259 Detail]
Download: Illinois-2019-HB2259-House_Amendment_001.html
Bill Title: DHFS-MCO PREFERRED DRUG LISTS
Status: 2019-07-12 - Public Act . . . . . . . . . 101-0062 [HB2259 Detail]
Download: Illinois-2019-HB2259-House_Amendment_001.html
| |||||||
| |||||||
| |||||||
| 1 | AMENDMENT TO HOUSE BILL 2259
| ||||||
| 2 | AMENDMENT NO. ______. Amend House Bill 2259 on page 3, | ||||||
| 3 | immediately below line 19, by inserting the following: | ||||||
| 4 | "A licensed physician recommended by the Rare Disease | ||||||
| 5 | Commission who is a rare disease specialist and possesses | ||||||
| 6 | scientific knowledge and medical training with respect to rare | ||||||
| 7 | diseases, and is familiar with drug and biological products and | ||||||
| 8 | treatment, shall be notified in advance to attend an Illinois | ||||||
| 9 | Drug and Therapeutics Advisory Board meeting when a drug or | ||||||
| 10 | biological product is scheduled to be reviewed in order to | ||||||
| 11 | advise and make recommendations on drugs or biological | ||||||
| 12 | products.".
| ||||||
